Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Discontinuïtat de Regressió Bayesiana× | Emparellament per puntuació de propensió× | |
|---|---|---|
| Camp≠ | Inferència causal | Estadística per a la recerca |
| Família≠ | Regression model | Process / pipeline |
| Any d'origen≠ | 2004-2016 | 1983 |
| Autor original≠ | Karabatsos & Walker; Chib & Jacobi | Paul Rosenbaum and Donald Rubin |
| Tipus≠ | Bayesian causal inference / quasi-experimental | Method |
| Font seminal≠ | Karabatsos, G., & Walker, S. G. (2004). Coherent inference in regression discontinuity designs with a Bayesian nonparametric approach. Journal of the American Statistical Association, 99(468), 1121-1131. link ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Àlies≠ | Bayesian RDD, Bayesian RD, Bayes RDD, Bayesian regression-discontinuity | PSM, propensity score weighting, covariate balance |
| Relacionats≠ | 5 | 3 |
| Resum≠ | Bayesian Regression Discontinuity Design (Bayesian RDD) embeds the classical RD framework — which estimates a local causal effect at a known assignment cutoff — within a Bayesian inferential engine. Prior distributions are placed on the regression functions on either side of the cutoff and on the treatment-effect parameter, yielding a full posterior distribution over the causal estimand rather than a single point estimate with a frequentist p-value. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateConjunt de dades ↗ |
|
|